12/3
10:37 am
hrow
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story [Yahoo! Finance]
Medium
Report
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story [Yahoo! Finance]
12/1
08:02 am
hrow
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS [Seeking Alpha]
Medium
Report
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS [Seeking Alpha]
11/24
07:00 am
hrow
Harrow to Present at Two Investor Conferences in December
Neutral
Report
Harrow to Present at Two Investor Conferences in December
11/18
07:00 am
hrow
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
Low
Report
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
11/12
02:53 pm
hrow
Harrow (NASDAQ:HROW) had its price target raised by analysts at LADENBURG THALM/SH SH from $64.00 to $66.00. They now have a "buy" rating on the stock.
Low
Report
Harrow (NASDAQ:HROW) had its price target raised by analysts at LADENBURG THALM/SH SH from $64.00 to $66.00. They now have a "buy" rating on the stock.
11/12
08:07 am
hrow
Harrow (NASDAQ:HROW) had its price target raised by analysts at HC Wainwright from $64.00 to $69.00. They now have a "buy" rating on the stock.
Low
Report
Harrow (NASDAQ:HROW) had its price target raised by analysts at HC Wainwright from $64.00 to $69.00. They now have a "buy" rating on the stock.
11/11
06:02 pm
hrow
Harrow (NASDAQ:HROW) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Harrow (NASDAQ:HROW) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
11/11
02:58 pm
hrow
Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans [Yahoo! Finance]
Low
Report
Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans [Yahoo! Finance]
11/10
04:12 pm
hrow
Harrow Health Non-GAAP EPS of $0.33 beats by $0.04, revenue of $71.6M misses by $2.1M [Seeking Alpha]
High
Report
Harrow Health Non-GAAP EPS of $0.33 beats by $0.04, revenue of $71.6M misses by $2.1M [Seeking Alpha]
11/10
04:05 pm
hrow
Harrow Announces Third Quarter 2025 Financial Results
High
Report
Harrow Announces Third Quarter 2025 Financial Results
10/27
07:00 am
hrow
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
Low
Report
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
10/15
09:07 pm
hrow
Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other [Seeking Alpha]
Medium
Report
Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other [Seeking Alpha]
10/9
06:58 pm
hrow
Harrow, Inc. (HROW): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Harrow, Inc. (HROW): A Bull Case Theory [Yahoo! Finance]
10/6
07:45 am
hrow
Harrow subsidiary ImprimisRx gets new CEO [Seeking Alpha]
Medium
Report
Harrow subsidiary ImprimisRx gets new CEO [Seeking Alpha]
10/6
07:44 am
hrow
ImprimisRx Announces Leadership Changes [Yahoo! Finance]
Medium
Report
ImprimisRx Announces Leadership Changes [Yahoo! Finance]
10/6
07:00 am
hrow
ImprimisRx Announces Leadership Changes
Medium
Report
ImprimisRx Announces Leadership Changes
10/1
09:12 am
hrow
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at B. Riley.
Low
Report
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at B. Riley.
9/29
09:04 am
hrow
Harrow (NASDAQ:HROW) was given a new $70.00 price target on by analysts at Lake Street Capital.
Low
Report
Harrow (NASDAQ:HROW) was given a new $70.00 price target on by analysts at Lake Street Capital.
9/29
08:05 am
hrow
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $64.00 price target on the stock.
Low
Report
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $64.00 price target on the stock.
9/26
07:19 am
hrow
Harrow to Acquire Melt Pharmaceuticals [Yahoo! Finance]
Low
Report
Harrow to Acquire Melt Pharmaceuticals [Yahoo! Finance]
9/26
07:00 am
hrow
Harrow to Acquire Melt Pharmaceuticals
Low
Report
Harrow to Acquire Melt Pharmaceuticals
9/25
05:35 pm
hrow
Harrow Launches Harrow Access for All (HAFA) [Yahoo! Finance]
Low
Report
Harrow Launches Harrow Access for All (HAFA) [Yahoo! Finance]
9/25
04:05 pm
hrow
Harrow Launches Harrow Access for All (HAFA)
Low
Report
Harrow Launches Harrow Access for All (HAFA)
9/24
08:07 am
hrow
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $63.00 price target on the stock.
Medium
Report
Harrow (NASDAQ:HROW) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $63.00 price target on the stock.
9/23
02:23 pm
hrow
Harrow (NASDAQ:HROW) had its price target raised by analysts at B. Riley from $65.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Harrow (NASDAQ:HROW) had its price target raised by analysts at B. Riley from $65.00 to $70.00. They now have a "buy" rating on the stock.